Yalonda Howze - 30 Mar 2023 Form 4 Insider Report for Codiak BioSciences, Inc.

Role: Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary
Signature: /s/ Yalonda Howze
Issuer symbol: N/A
Transactions as of: 30 Mar 2023
Net transactions value: -$318
Form type: 4
Filing time: 30 Mar 2023, 18:01:07 UTC
Previous filing: 26 Jan 2023
Next filing: 05 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDAKQ	Common Stock	Sale	$318	-1,628	-18%	$0.1955^*	7,458	30 Mar 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary